© 1982 Oxford University Press
research-article |
The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine
Division of Cytopathology, Institute for Experimental Pathology, German Cancer Research Center D-6900 Heidelberg, FRG
1To whom reprint requests should be addressed.
Different doses of N-nitrosomorpholine (NNM) (80, 120, 160, 200 mg/l drinking water) were administered for various periods of time (1, 4, 7, 14, 20 weeks) to male Sprague-Daw-ley rats in order to investigate the dose dependence and sequential appearance of preneoplastic and neoplastic lesions in the liver. With all dose levels studied a sequence was established leading from dear cell and acidophilic cell glycogen storage foci through mixed cell foci and neoplastic nodules to hepatocellular carcinomas. The first appearance and frequency of the different lesions investigated proved dependent on dose of carcinogen administered. Morphometric analysis demonstrated that the rare small clear cell foci apparent after 7 weeks treatment with NNM increase in number and size with progression through the sequence to carcinomas without further administration of carcinogen. No evidence was found to suggest that pronounced focal populations were reversible upon cessation of NNM-treatment under the present experimental conditions.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Dombrowski, C. M. Jost, S. Manekeller, and M. Evert Cocarcinogenic Effects of Islet Hormones and N-Nitrosomorpholine in Hepatocarcinogenesis after Intrahepatic Transplantation of Pancreatic Islets in Streptozotocin-Diabetic Rats Cancer Res., August 1, 2005; 65(15): 7013 - 7022. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sukata, S. Uwagawa, K. Ozaki, K. Sumida, K. Kikuchi, M. Kushida, K. Saito, K. Morimura, K. Oeda, Y. Okuno, et al. {alpha}2-Macroglobulin: A Novel Cytochemical Marker Characterizing Preneoplastic and Neoplastic Rat Liver Lesions Negative for Hitherto Established Cytochemical Markers Am. J. Pathol., November 1, 2004; 165(5): 1479 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ittrich, E. Deml, D. Oesterle, K. Kuttler, W. Mellert, S. Brendler-Schwaab, H. Enzmann, L. Schladt, P. Bannasch, T. Haertel, et al. Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report Toxicol Pathol, January 1, 2003; 31(1): 60 - 79. [Abstract] [PDF] |
||||
![]() |
H. Enzmann, C. Kuhlem, G. Kaliner, E. Loser, and P. Bannasch Rapid Induction of Preneoplastic Liver Foci in Embryonal Turkey Liver by Diethylnitrosamine Toxicol Pathol, September 1, 1995; 23(5): 560 - 569. [Abstract] [PDF] |
||||
![]() |
E. Rinde, R. Hill, A. Chiu, and B. Haberman Proliferative Hepatocellular Lesions of the Rat: Review and Future Use in Risk Assessment Toxicology and Industrial Health, January 1, 1987; 3(1): 145 - 166. [PDF] |
||||
![]() |
A. Columbano, S. Dessi, G. M. Ledda-Columbano, C. Chiodino, P. Coni, P. Pani, and K. N. Rao HMP-Shunt and Cholesterol Metabolism in Experimental Models Involving Normal and Preneoplastic Liver Growth Toxicol Pathol, January 1, 1987; 15(1): 43 - 50. [Abstract] [PDF] |
||||
![]() |
P. Bannasch, M. A. Moore, F. Klimek, and H. Zerban Biological markers of preneoplastic foci and neoplastic nodules in rodent liver Toxicol Pathol, February 1, 1982; 10(2): 19 - 34. [Abstract] [PDF] |
||||



